Lataa...
Non‐responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
AIMS: To determine the characteristics of “non‐responders” to intravitreal bevacizumab treatment in choroidal neovascularisation (CNV). METHODS: Forty‐three patients with visual loss due to neovascular age‐related macular disease (ARMD) (44 eyes) underwent intravitreal injections of 1.25 mg (0.05 ml...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000982/ https://ncbi.nlm.nih.gov/pubmed/17537784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.113902 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|